A key panel of the US Food and Drug Administration (FDA) held a meeting during which they discussed the potential use of Covid-19 vaccines in children under 12 years of age.
The FDA’s Vaccines and Related Biological Products Advisory Committee met in the open session on Thursday to discuss data needed to support authorization and/or licensure of Covid-19 vaccines for use in paediatric populations, Xinhua news agency.
Read More: https://www.bhaskarlive.in/us-fda-panel-discusses-covid-vax-for-kids-under-12/


No comments:
Post a Comment